科研之友
微信
新浪微博
Facebook
分享链接
摘要
With the recent approval of Kythera Biopharmaceuticals (Westlake Village, California) submental fat injectable treatment Kybella, there comes a lot of excitement but, also a bit of concern. The idea of having a nonsurgical, nonliposuction treatment for people who have a double chin is certainly exciting. The hope has been that this new treatment will provide opportunities for the many people out there who are focused on the appearance of their submental fullness to have access to a safe, affordable, and reliable treatment. With the approval of this product, there are several misconceptions that the authors herein discuss.
- 出版日期2015-9
